文献速递肝病

年轻起病代谢功能障碍相关脂肪性肝病肝硬化的危险因素与定义

Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-09-16

研究基于 NASH CRN 队列中 2395 例经活检证实的 MASLD 成人,其中 234 例(9.8%)有肝硬化,将肝硬化最年轻四分位(<50 岁)定义为年轻起病。调整人口学和代谢因素后,高遗传风险评分(OR 2.33)和 2 型糖尿病(OR 3.74)与 50 岁前肝硬化独立相关。

要点

  • MASLD 肝硬化患者中约四分之一在 50 岁前起病,即年轻起病。
  • 年轻起病肝硬化与保护性 HSD17B13 变异携带率较低相关。
  • 高遗传风险评分和 2 型糖尿病是 50 岁前肝硬化的独立危险因素。

核心结论

  • 约四分之一 MASLD 肝硬化患者在 50 岁前起病,且具有更高遗传风险和更高 2 型糖尿病患病率等特征。

研究设计与样本

  • 研究纳入 NASH CRN 中经活检证实的 MASLD 成人,进行 DNA 基因分型和遗传风险评分计算,将肝硬化最年轻四分位定义为年轻起病肝硬化(<50 岁)。
  • 研究共纳入 2395 例参与者,其中 234 例(9.8%)有 MASLD 肝硬化,肝硬化患者中位年龄 58.4 岁、中位 BMI 34.9 kg/m2、66% 合并 2 型糖尿病。

主要发现

  • 年轻起病肝硬化组(<50 岁)保护性 HSD17B13 变异携带率低于非年轻起病组(24% vs 34%,P = .004)。
  • 与 50 岁以下非肝硬化 MASLD 参与者(n = 999)相比,50 岁以下肝硬化患者更常有 2 型糖尿病、BMI ≥35kg/m2、更高碱性磷酸酶和更低丙氨酸氨基转移酶。
  • 调整人口学和代谢因素后,高遗传风险评分(OR 2.33,95%CI 1.26-4.23,P = .006)和 2 型糖尿病(OR 3.74,95%CI 2.08-6.82,P < .001)与 50 岁前肝硬化独立相关。

关键数值与推荐

  • 年轻起病肝硬化定义为肝硬化参与者中年龄最年轻四分位,即 <50 岁。
  • 遗传风险评分以 PNPLA3 和 TM6SF2 风险等位基因加上野生型 HSD17B13 等位基因之和计算,按中位数二分为高/低。
  • 高遗传风险评分与 50 岁前肝硬化相关(OR 2.33,95%CI 1.26-4.23,P = .006)。
  • 2 型糖尿病与 50 岁前肝硬化相关(OR 3.74,95%CI 2.08-6.82,P < .001)。

临床怎么用

  • 对 50 岁以下 MASLD 患者,尤其合并 2 型糖尿病者,应关注肝硬化风险并考虑遗传风险评分评估。
  • 年轻起病肝硬化患者可能表现为碱性磷酸酶升高而丙氨酸氨基转移酶较低,临床需注意识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Cirrhosis from metabolic dysfunction-associated steatotic liver disease (MASLD) usually develops with advancing age, yet a subset of patients presents at younger ages. We examined genetic and metabolic factors associated with younger-onset MASLD cirrhosis. METHODS: Adults with biopsy-proven MASLD enrolled in the NASH CRN were included. DNA was genotyped, and a genetic risk score (GRS) was calculated as the sum of risk alleles in PNPLA3 and TM6SF2 plus the wild-type HSD17B13 allele, dichotomized at the median (low vs high), in addition to evaluation of previously published weighted GRSs. Younger-onset cirrhosis was defined as the youngest quartile among participants with cirrhosis. Multivariable logistic regression evaluated factors associated with younger-onset cirrhosis. RESULTS: Among 2395 participants, 234 (9.8%) had MASLD cirrhosis (median age, 58.4 years; body mass index, 34.9 kg/m2; 66% with type 2 diabetes mellitus [T2DM]). Younger-onset cirrhosis was defined as the lowest quartile, which was <50 years and was associated with a lower prevalence of the protective HSD17B13 variant (24% vs 34%; P = .004). Compared with participants with noncirrhotic MASLD under 50 years (n = 999), those with cirrhosis more often had T2DM, body mass index ≥35kg/m2, higher alkaline phosphatase, and lower alanine aminotransferase. In multivariable models adjusting for demographic and metabolic factors, high GRS (odds ratio, 2.33; 95% confidence interval, 1.26-4.23; P = .006) and T2DM (odds ratio, 3.74; 95% confidence interval, 2.08-6.82; P < .001) remained independently associated with cirrhosis under age 50. CONCLUSIONS: One-quarter of participants with MASLD cirrhosis present before age 50 years and have distinct features, including higher genetic risk and a greater prevalence of T2DM.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ajmera V, Schwantes-An L, Díaz LA, et al. Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease Cirrhosis. Clin Gastroenterol Hepatol. 2026. PMID: 42749101. doi:10.1016/j.cgh.2026.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。